223 - Safety, Tolerability, and Immunogenicity of the mRNA-1345 RSV Vaccine in Solid Organ Transplant Recipients Aged ≥18 Years

Presenting Author(s)

• 

  Erick F. Mayer, MD (he/him/his)

  Director, Clinical Development
  Moderna, Inc.
  Cambridge, MA, United States

  Slides

Co-Author(s)

• 

  Ann R. Falsey, MD

  Dr
  University of Rochester School of Medicine
  Rochester, New York, United States
• 

  Cameron R. Wolfe, MBBS, MPH, FAST, FIDSA

  Professor of Medicine
  Duke University
  Durham, NC, United States
• EH

  Erica Herc, MD

  Senior Staff, Infectious Diseases
  Henry Ford Hospital
  Detroit, Michigan, United States
• FB

  Fiona Burns, PhD

  University College London
  London, England, United Kingdom
• 

  Dima Kabbani, MD, MSc

  Assistant Professor
  University of Alberta
  Edmonton, AB, Canada
• 

  Deepali Kumar, MD, MSc, FRCPC

  Professor of Medicine
  University Of Toronto
  Toronto, ON, Canada
• CG

  Christina Grassi, MD

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• JW

  Joseph Whitten, MD

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• AR

  Anthony Rizk, PharmD, MBA

  Senior Manager
  Moderna, Inc.
  Cambridge, Massachusetts, United States
• CR

  Caroline Reuter, MD, MSCI

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• AC

  Avi Collins, BScN

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• AM

  Anisha Mannan, MS

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• AK

  Archana Kapoor, PhD

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• SS

  Sonia K. Stoszek, PhD

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• JD

  Jiejun Du, PhD

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• JM

  Jenni Mou, PhD

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• LL

  Lan Lan, PhD

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• HZ

  Honghong Zhou, Ph.D.

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• EW

  Eleanor Wilson, MD, MHS

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• JG

  Jaya Gowami, MD

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• RD

  Rituparna Das, M.D.

  Moderna, Inc.
  Cambridge, Massachusetts, United States
• FP

  Frances Priddy, MD, MPH (she/her/hers)

  Executive Director, Clinical Development
  Moderna, Inc.
  Cambridge, Massachusetts, United States